Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | VRTX | BMY | GILD |
| Company | Clovis Oncology Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.0808 | 297.91 | 495.62 | 58.91 | 92.31 |
| High | 0.0977 | 298.48 | 496.33 | 59.73 | 92.51 |
| Low | 0.0766 | 292.33 | 485.20 | 58.26 | 91.30 |
| Last | 0.0812 | 296.67 | 487.06 | 58.46 | 92.33 |
| Change | -0.0048 | -4.77 | -7.55 | +0.05 | -0.30 |
| % Change | -5.58% | -1.58% | -1.53% | +0.09% | -0.32% |
| Volume | 24,516,400 | 2,065,916 | 535,534 | 5,899,558 | 4,176,640 |
| 20-Day Average Volume | 9,433,500 | 2,248,913 | 1,144,488 | 10,551,113 | 6,762,985 |
| Previous Close | 0.0860 | 301.44 | 494.61 | 58.41 | 92.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 315.91 | 484.23 | 54.76 | 90.60 |
| 20-Day Raw Stochastic | 1.73% | 13.47% | 44.27% | 72.44% | 49.59% |
| 20-Day Relative Strength | 23.83% | 34.27% | 52.26% | 64.39% | 60.19% |
| Weighted Alpha | -91.19 | +5.76 | +33.34 | +25.20 | +31.28 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 96% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | -7.69% since 11/07/24 | -2.82% since 11/07/24 | +6.97% since 11/07/24 | -5.83% since 11/07/24 |
| Low | 0.0760 on 12/16/22 | 292.33 on 11/14/24 | 485.20 on 11/14/24 | 53.97 on 11/08/24 | 91.29 on 11/14/24 |
| High | 0.1439 on 12/14/22 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -8.46% since 10/14/24 | +0.71% since 10/14/24 | +11.12% since 10/14/24 | +8.40% since 10/14/24 |
| Low | 0.0760 on 12/16/22 | 292.33 on 11/14/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.80 on 10/15/24 |
| High | 0.3772 on 12/01/22 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -7.92% since 08/14/24 | +3.57% since 08/14/24 | +20.89% since 08/14/24 | +24.35% since 08/14/24 |
| Low | 0.0760 on 12/16/22 | 292.33 on 11/14/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 1.3100 on 10/04/22 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -4.57% since 05/14/24 | +13.92% since 05/14/24 | +30.90% since 05/14/24 | +36.28% since 05/14/24 |
| Low | 0.0760 on 12/16/22 | 292.33 on 11/14/24 | 428.62 on 05/15/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 3.2500 on 07/08/22 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 162,033,952 | 127,376,408 | 118,465,824 | 115,323,600 |
| Shares Outstanding, K | 144,955 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 30,660,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -56,010,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.24 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/09/22 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.55 | 0.00 | 50.44 | 21.30 |